This paper presents a structured patient teaching plan for Tay-Sachs disease, a fatal genetic lipid-storage disorder caused by mutations in the HEXA gene. The plan outlines desired patient outcomes and provides educational content covering the genetic basis of the disease, available treatment options, prognosis, support organizations, and considerations for pregnancy. The paper also addresses the ethical implications of personal genetic information — including informed consent, policy impacts, and family effects — and examines how ethical and legal considerations, including abortion law, influence a couple's decision-making when a Tay-Sachs diagnosis is made during pregnancy.
The following outcomes guide this teaching plan for patients and families affected by Tay-Sachs disease:
The patient will understand the genetic nature of Tay-Sachs disease. The patient will understand the treatment options available for Tay-Sachs disease. The patient will understand the prognosis of Tay-Sachs. The patient will know about support groups and appropriate referrals. The patient will understand relevant information about Tay-Sachs in pregnancy.
Tay-Sachs disease is a fatal genetic disorder related to the storage of lipids in quantities that are harmful to the tissues and nerve cells of the brain. The lipid involved is ganglioside GM2. Tay-Sachs is caused by insufficient activity of the beta-hexosaminidase A enzyme, which catalyzes the biodegradation of acidic fatty materials known as gangliosides. As the brain develops, gangliosides are generated and biodegrade rapidly in the early years of life. The disease is extremely rare; however, it leads to the death of affected infants at an early age (Melillo & Leisman, 2010).
Mutations in the HEXA gene are responsible for causing Tay-Sachs disease. The HEXA gene provides instructions for the production of the beta-hexosaminidase A enzyme. This mutation disrupts both the production and activity of the enzyme, leading to the signs and symptoms of Tay-Sachs disease (Melillo & Leisman, 2010).
There is currently no cure for Tay-Sachs disease itself. However, management of symptoms is possible and can help make the patient more comfortable.
Children who have the disease typically experience symptoms that worsen as they age. Death usually occurs by the time they are 4 to 5 years old.
Infants with the disorder generally appear normal until approximately 3 to 6 months of age, after which they become blind, mute, and deaf, and are unable to swallow. Muscle atrophy and paralysis also develop, followed by additional neurological symptoms such as seizures, dementia, and an exaggerated startle reflex to slight noises. The disease ultimately leads to death at around 4 years of age.
Several support groups and organizations assist families affected by Tay-Sachs disease. These include the National Tay-Sachs and Allied Diseases Association, the March of Dimes, Genetic Alliance, and the National Organization for Rare Disorders (NORD). These organizations help educate the public about Tay-Sachs, offer genetic testing to detect whether partners are at risk, and provide counseling for those who may be affected.
"Pre-conception testing and patient comprehension evaluation"
"Informed consent, policy, and family impact ethics"
"Autonomy, beneficence, and abortion law tensions"
You’re 37% through this paper. Sign up to read the remaining 3 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.